, the trainer of Medina Spirit, was suspended by Churchill Downs for two years for "reckless practices and substance violations". In Kentucky, betamethasone is classified as a Class C drug that is permitted for therapeutic use in horses, but requires a 14-day withdrawal time. Any amount of the drug detected in post-race testing is a violation and could result in a disqualification. In a news conference on May 9, Baffert said that Medina Spirit was never administered betamethasone. In addition to a request for a split drug sample, Baffert requested an independent DNA and follicle test. He told reporters that he would fight the issue "...tooth and nail because I owe it to the horse, I owe it to the owner, and I owe it to our industry." Shortly thereafter,
Churchill Downs suspended Baffert from entering any horses at their racetrack pending the outcome of the commission's investigation. On May 11, Baffert released a statement through his attorney saying that
veterinarians treated Medina Spirit with Otomax, an
antifungal ointment, from after the horse's second-place finish in the Santa Anita Derby until the day before the Kentucky Derby. Baffert claimed that Otomax was used to treat
dermatitis on the horse's hind end, and that he did not realize the ointment had betamethasone until after the positive test was reported. Baffert said he never attempted to "game the system or get an unfair advantage", and quoted
pharmacologists who told him that "21 picograms of betamethasone would have no effect on the outcome of the race." On June 2, Churchill Downs announced that the split sample had also tested positive. Churchill Downs announced that it had suspended Baffert for two years as a result of this and earlier positive tests at other racetracks. Bill Carstanjen stated for Churchill Downs that "given these repeated failures over the last year, including the increasingly extraordinary explanations, we firmly believe that asserting our rights to impose these measures is our duty and responsibility." At the time of his death, Medina Spirit was still an active
racehorse, even recently winning the October 2021
Awesome Again Stakes and then afterwards finishing second in the
November 2021 Breeder's Cup Classic. Three days before the horse's death, Baffert's attorney Craig Robinson publicly acknowledged that the kind of betamethasone which Medina Spirit was injected with was banned by Kentucky state rules, while also alleging it was used to improve his skin condition rather than enhance performance. Because Medina Spirit was disqualified,
Mandaloun was named the winner. Baffert had the right to appeal the ruling per the Kentucky Horse Racing Commission rules, which he did along with Amr F. Zedan, the owner of Medina Spirit. His appeal was later dismissed on April 18, 2022. Medina Spirit's disqualification for betamethasone is the first drug-related disqualification of a Kentucky Derby winner since
Dancer's Image was disqualified for
phenylbutazone, a
nonsteroidal anti-inflammatory drug (NSAID), following the
1968 edition. It would be the second disqualification in three years (
Maximum Security was disqualified in
2019 due to interference), and the third disqualification in the 147-year history of the race. In December 2024,
W.D. Ky federal judge Claria Horn Boom dismissed the
class action filed by thirty
plaintiffs led by Michael Beychok. Earlier, the
United States Court of Appeals for the Sixth Circuit also dismissed similar
bettors' lawsuit led by Anthony Mattera on May. ==Results==